Atlas Trials

A Study to Assess Cannabidiol Oral Solution With Vigabatrin as Initial Therapy in Participants With Infantile Spasms

Clinical trial NCT03421496 · TERMINATED

Trial details

NCT number
NCT03421496
Sponsor
Radius Pharmaceuticals, Inc.
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Infantile Spasm
Start date
2018-09-05
Primary completion
2019-05-29
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.